(See also Overview of Skin Cancer Overview of Skin Cancer Skin cancer is the most common type of cancer and commonly develops in sun-exposed areas of skin. Skin cancers can be found on any location of the body but are most commonly diagnosed on the... read more .)
Mean age at diagnosis is about 75 years. Merkel cell carcinoma also affects younger patients who are immunosuppressed. Other risk factors include cumulative exposure to ultraviolet light, exposure to the Merkel cell polyomavirus, and having another cancer (eg, multiple myeloma Multiple Myeloma Multiple myeloma is a cancer of plasma cells that produce monoclonal immunoglobulin and invade and destroy adjacent bone tissue. Common manifestations include lytic lesions in bones that cause... read more , chronic lymphocytic leukemia Chronic Lymphocytic Leukemia (CLL) Chronic lymphocytic leukemia (CLL) is characterized by progressive accumulation of phenotypically mature malignant B lymphocytes. Primary sites of disease include peripheral blood, bone marrow... read more , melanoma Melanoma Malignant melanoma arises from melanocytes in a pigmented area (eg, skin, mucous membranes, eyes, or central nervous system). Metastasis is correlated with depth of dermal invasion. With metastasis... read more ).
Lymphatic spread is common.
Symptoms and Signs of Merkel Cell Carcinoma
Skin lesions are typically firm, shiny, flesh-colored or bluish-red, and nodular. Their most characteristic clinical findings are rapid growth and absence of pain and tenderness.
Although Merkel cell carcinoma can affect any part of the skin, it is most common on sun-exposed areas (eg, face, upper extremities).
Diagnosis of Merkel Cell Carcinoma
Biopsy
Diagnosis of Merkel cell carcinoma is by biopsy.
Most patients have metastatic disease at presentation, and the prognosis is poor.
Treatment of Merkel Cell Carcinoma
Determined by staging
Treatment of Merkel cell carcinoma is determined by cancer staging and typically includes wide local excision, often followed by radiation therapy, lymph node dissection, or both.
Systemic therapy (eg, with avelumab, pembrolizumab, retifanlimab, or another programmed death receptor 1 [PD-1] inhibitor or conventional chemotherapy) may be indicated for metastatic or recurrent cancer.
Prevention of Merkel Cell Carcinoma
Because Merkel cell carcinoma is associated with ultraviolet (UV) exposure, a number of measures are recommended to limit exposure.
Sun avoidance: Seeking shade, minimizing outdoor activities between 10 AM and 4 PM (when sun's rays are strongest), and avoiding sunbathing and the use of tanning beds
Use of protective clothing: Long-sleeved shirts, pants, and broad-brimmed hats
Use of sunscreen: At least sun protection factor (SPF) 30 with broad-spectrum UVA/UVB protection, used as directed (ie, reapplied every 2 hours and after swimming or sweating); should not be used to prolong sun exposure
Drugs Mentioned In This Article
Drug Name | Select Trade |
---|---|
avelumab |
BAVENCIO |
pembrolizumab |
Keytruda |
retifanlimab |
ZYNYZ |